Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6 - Related Studies

Study Comparing Optimized 5-FU Dosing and Standard Dosing in Metastatic Colorectal Cancer Patients Treated With mFOLFOX6 (PROFUSE)

This study has been terminated.

( Study terminated due to slow enrollment. )

Study NCT01468623 Information provided by Myriad Genetic Laboratories, Inc.

First Received on November 1, 2011. Last Updated on January 29, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

Colorectal Neoplasms

More general conditions related to this trial

Interventions listed in this trial

Standard of care

Additional drug interventions recognized in this trial

Bevacizumab
Fluorouracil

More general drug interventions related to this trial

Sponsors listed in this trial